Related Experiment Video
Updated: Apr 27, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Intravenous thrombolysis for acute ischaemic stroke in the setting of rivaroxaban use
Andrew J Neal1, Bruce C V Campbell1, Arvind Chandratheva1
1Department of Medicine and Neurology, Royal Melbourne Hospital, University of Melbourne, Grattan Street, Parkville, VIC 3052, Australia.
Abstract:
The risk of thrombolysis in patients taking novel anticoagulants remains unclear. We describe a patient with a large acute ischaemic stroke, who had a low calibrated anti-factor Xa level, who safely received thrombolysis 15-17 hours after standard dose rivaroxaban without subsequent intracerebral haemorrhage.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Hemorrhagic Stroke l: Introduction

